Flurazepam Hydrochloride Capsule — FDA Drug Shortage

Current — Chartwell Molecular Holdings LLC

The FDA lists a drug shortage record for Flurazepam Hydrochloride Capsule (capsule) from Chartwell Molecular Holdings LLC with status Current. The shortage was first posted on Aug 3, 2022.

Shortage details

Status
Current
Company
Chartwell Molecular Holdings LLC
Package NDC
62135-736-90
Dosage Form
Capsule
Presentation
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)
Initial Posting
Aug 3, 2022

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.